Serum Institute of India seeks indemnity against liabilities: Sources
India | Jun 03, 2021, 10:15 AM ISTIndia has so far not given any manufacturer of a Covid-19 vaccine indemnity against the costs of compensation for any severe side effects.
India has so far not given any manufacturer of a Covid-19 vaccine indemnity against the costs of compensation for any severe side effects.
The COVID-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trial after showing promising results in Phase 1 and 2 clinical trials.
Pratap Chandra, a resident of Lucknow, stated that after listening to a press briefing of ICMR where it was mentioned that antibodies in sufficient quantities are formed in the body against the virus after taking the first dose, he got an antibody test to determine the level of antibodies formed in his body.
The BHU research has come amid reports that the government is mulling to tweak its vaccination strategy.
Delhi received fresh stock of Covaxin and Covishield for the 45 plus age group on Sunday, AAP MLA Atishi said, and lamented that vaccination for the youth at government centres has been shut for more than a week owing to lack of jabs for this category.
Government could approve single-dose regimen for Covishield after a study to review the impact of its recent decision to extend the doses' interval.
BJP leaders "criticise and abuse" Arvind Kejriwal whenever he works for the people, Delhi Deputy Chief Minister Manish Sisodia alleged on Monday.
The Centre on Monday told Supreme Court that entire eligible population will be vaccinated against Covid-19 by 2021-end.
Serum Institute of India (SII) has informed the government that it will be able to manufacture and supply nine to 10 crore doses of Covishield in June, official sources said on Sunday amid complaint by states about the shortage of anti-coronavirus vaccine jabs.
Raja Krishnamoorthi said he is doing everything to get the Biden administration provide excess vaccines not used in the United States to India.
The Delhi government has floated a Global Expression of Interest (EOI) for procurement of 1 crore doses of Covid-19 vaccines on an urgent basis.
Vaccine, being a biological product, takes time for harvesting and quality testing and this cannot be done overnight to ensure a safe product, the Union Health Ministry said on Friday.
There are many parts of the world where one shot has been dispensed to health workers or frontline workers and the second shot has not been forthcoming, USAID told lawmakers on Thursday.
Prime Minister Narendra Modi has asked Health Minister Harsh Vardhan to counter opposition parties' narratives on vaccination with facts.
Around 4K people above the age of 45 yrs who have taken either one or both doses of any of these two vaccines will be reviewed, according to Dr Tarun Bhatnagar, senior scientist at ICMR's NIE in Chennai.
As the country faces the deadly second wave of coronavirus, India has become the second country after the United States to cross 20 crore cumulative COVID-19 vaccination coverage.
AAP MLA Atishi Marlena has informed that Delhi on Monday received nearly 1.5 lakh doses of Covishield for the 45 plus age group.
According to the health ministry, a total of 19,60,51,962 vaccine doses have been administered through 28,16,725 sessions, as per the provisional report till 7 am today.
A total of 500 Covishield vials have been reported missing from a government hospital in Hyderabad, police said on Friday.
Two doses of the Oxford/AstraZeneca vaccine have shown to prevent around 85 to 90 per cent of symptomatic COVID-19 infections, the first real-world data from Public Health England (PHE) has found.
Top News
Latest News